4 ways dwindling pharma sales detailing will affect the cloud
medical marketing & media | 13 october 2016
To read the full article in Medical Marketing & Media click here.
PA life sciences expert Milind Kamkolkar weighs in on one key way the decline in pharma sales could affect the cloud.
According to Milind: “We will see a shift from siloed content orchestration to “experience-driven” content orchestration, with a need for more unstructured data types and behavioral analytics.”
How organisations can stop wasting their best ideas
download the report
Milind added: “As a result, dynamic content approval processes may move to artificial intelligence with built-in compliance. Dashboards with evolved key performance indicators will tell a story rather than just provide metrics. As a whole, the focus will move from next best action to next best options with personalization as a key focus, while maintaining the balance between physical engagement and digital preferences.”
Milind concluded: “Historical retention of changes to content will be required, particularly for European countries where regulations are strict regarding off-label and promotional activities. Moving forward, mobile first as a deployment capability will be the norm, with web-based delivery de-prioritized for detailing.”